Dorado, PRCIK 19104564 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
22 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Stoke Therapeutics Inc | 5.40M | $171.54M | 34.7% | 0 | Held |
| 2 | Gh Research PLC | 10.41M | $132.16M | 26.8% | +1.81M | Added |
| 3 | Cullinan Therapeutics Inc | 8.96M | $92.77M | 18.8% | +3.20M | Added |
| 4 | Denali Therapeutics Inc |
| 1.74M |
| $28.71M |
| 5.8% |
| +1.48M |
| Added |
| 5 | C4 Therapeutics Inc | 7.10M | $13.56M | 2.7% | 0 | Held |
| 6 | Xencor Inc | 705.6K | $10.80M | 2.2% | +705.6K | New |
| 7 | Immatics N.V | 922.0K | $9.68M | 2.0% | +922.0K | New |
| 8 | Tscan Therapeutics Inc | 8.02M | $8.02M | 1.6% | +161.8K | Added |
| 9 | Passage Bio Inc | 623.7K | $7.36M | 1.5% | 0 | Held |
| 10 | Korro Bio Inc | 677.9K | $5.43M | 1.1% | +677.9K | New |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio